Guideline for the notification of serious breaches of Regulation (EU) No 536/2014 or the clinical trial protocol
European Union (EU) pharmaceutical legislation known as the Clinical Trials Regulation entered into application on 31 January 2022. It aims to ensure the EU offers an attractive and favourable environment for carrying out clinical research on a large scale, with high standards of public transparency and safety for clinical trial participants.
On 31 January 2022, the Regulation repealed the Clinical Trials Directive (EC) No. 2001/20/EC and national implementing legislation in the EU Member States, which regulated clinical trials in the EU until the Regulation's entry into application.
A transition period applies to clinical trial submission under the Regulation.
Table of Contents
3. How to report a serious breach
4. Clarification on reporting requirements
5. Reporting serious breaches – Points to consider
6. Responsibilities of parties involved in the notification of a serious breach
7. General considerations for serious breaches
8. Possible actions taken by the EU/EEA Member States concerned (MSC)
Appendix I – Examples of serious breaches
Appendix II – Points to consider for sponsors in relation to the assessment of a breach
Appendix III a – Template form for reporting serious breaches
Appendix III b – Information to be submitted with a notification of a serious breach
Source: Medicines & Healthcare products Regulatory Agency, the UK.
Clinical Research News
Upcoming Clinical Research Training and Conferences
-
on demandACROSS Global Training AcademyOnline
-
29 September 2023 – 02 October 2024SCDM (Society of Clinical Data Management)United States
-
21 – 23 May 2024InformaBelgium
-
03 – 04 June 2024The Society for Clinical Research Sites (SCRS)United States
-
16 – 17 July 2024The Society for Clinical Research Sites (SCRS)Australia
-
27 September – 29 October 2024The Society for Clinical Research Sites (SCRS)United States
Připravované klinické studie
-
University of Novi SadNáborAkutní poškození ledvinSrbsko
-
The First Affiliated Hospital of Zhejiang Chinese...NáborZánětlivá odezva | Tourettův syndrom u dětí | Potravinová intoleranceČína
-
University of Rome G. MarconiUniversity of Bologna; University of the Italian SwitzerlandZatím nenabírámeStres | Nespavost | Poporodní depreseItálie
-
Selcuk UniversityZatím nenabírámeGamifikace | Studenti ošetřovatelství | Multiple Intelligence Theory | Disaster NursingKrocan
-
NuvoAir Medical PCOptum, Inc.Zatím nenabírámeCOPD | Exacerbace CHOPN | Kardio/Pulm: Srdeční selhání
-
Regeneron PharmaceuticalsIntellia TherapeuticsZatím nenabíráme
-
Centro di Riferimento Oncologico - AvianoNáborMetastatický nemalobuněčný karcinom plic | Mutace genu ALKItálie
-
Omphis FoundationNábor
-
Institut de cancérologie Strasbourg EuropeContinuum Plus Santé; Plateforme nationale qualité de vie et cancer; WeShareZatím nenabírámeNovotvary prsu | Novotvary plic | Novotvary prostaty | Kolorektální novotvaryFrancie
-
Al-Balqa Applied UniversityLuzmila HospitalZatím nenabíráme
-
Musculoskeletal Injury Rehabilitation Research...The Geneva Foundation; Uniformed Services University (USU) of the Health Sciences a další spolupracovníciZatím nenabírámeNízkoúrovňová laserová terapie | Fotobiomodulační terapie | Vylepšení výkonu | Fotomedicína | Quadriceps | Připravenost na speciální operace
-
The Seventh Affiliated Hospital of Sun Yat-sen...Huizhou Municipal Central Hospital; Dongguan Hospital of Traditional Chinese... a další spolupracovníciNáborVývoj a validace modelu rizika pooperačních refrakčních zlomenin pro osteoporotické zlomeniny páteřeZlomenina osteoporózy | Kompresní zlomenina | Osteoporóza obratlů | Proveďte ošetření PVP / PKPČína